BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Career Advice

  Survivor Syndrome: 3 Steps for Keeping Your Career on Track After Layoffs

  Layoffs leave more than empty desks—they leave uncertainty, guilt and anxiety. Three simple steps will help you regain control of your work, well-being and career.

  March 19, 2025

   · 

  5 min read

   · 

  Angela Justice
• 

  Antibody-drug conjugate (ADC)

  Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics

  Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.

  March 19, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024.

  March 19, 2025

   · 

  9 min read
• Press Releases

  Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema

  March 19, 2025

   · 

  5 min read
• Press Releases

  Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board

  March 19, 2025

   · 

  5 min read
• Press Releases

  Ashvattha Therapeutics Accelerates Clinical Development Strategy with Leadership Appointment of Six Leading Retinal Specialists to Clinical Advisory Board

  March 19, 2025

   · 

  5 min read
• Press Releases

  Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States

  March 19, 2025

   · 

  6 min read
• Press Releases

  Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

  March 19, 2025

   · 

  5 min read
• Press Releases

  PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results

  March 19, 2025

   · 

  5 min read
• Press Releases

  Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

  March 19, 2025

   · 

  8 min read